Avraham Hampel
Corporate Officer/Principal at STEAKHOLDER FOODS LTD.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yaron Kaiser | M | 46 | - | |
| Jonathan Burgin | M | 63 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 years |
| David Gerbi | M | 44 | 5 years | |
| Sari Singer Kaufman | F | 44 | 3 years | |
| Arik Kaufman | M | 42 | 32 years | |
| Eli Arad | M | 51 | 6 years | |
| Daniel Spira | M | 69 | 19 years | |
| Michal Gilon Ohev Zion | M | 46 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 11 years |
| Ofer Goldberg | M | 52 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 years |
| Aharon Schwartz | M | 80 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 years |
| Ofer Gonen | M | 49 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | - |
| Shmuel Levy | M | 57 | 6 years | |
| Moran Attar Yossef | F | 41 | 1 years | |
| Simon Fried | M | - | - | |
| Idan Gal | M | - | - | |
| Yair Ayalon | M | - | - | |
| Mor Glotter-Nov | F | - | 2 years | |
| Itamar Atzmony | M | 37 | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sharon Fima | M | 49 | 30 years | |
| Omri Schanin | M | 34 | - | |
| Michal Forkosh | F | - | - | |
| Eitan Noah | M | - | 2 years | |
| Daniel Ayalon | M | 68 | 2 years | |
| Steven H. Lavin | M | 68 | 2 years | |
| Dan Kozlovski | M | 39 | 5 years | |
| Guy Hefer | M | 42 | 3 years | |
| Lior Maimon | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 22 | 81.48% |
| United States | 5 | 18.52% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Avraham Hampel
- Personal Network
